• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A novel quantitative assessment of whole blood thrombogenicity in patients treated with a non-vitamin K oral anticoagulant.

作者信息

Sueta Daisuke, Kaikita Koichi, Okamoto Nobukazu, Arima Yuichiro, Ishii Masanobu, Ito Miwa, Oimatsu Yu, Iwashita Satomi, Takahashi Aya, Nakamura Eiichi, Hokimoto Seiji, Mizuta Hiroshi, Ogawa Hisao

机构信息

Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

出版信息

Int J Cardiol. 2015 Oct 15;197:98-100. doi: 10.1016/j.ijcard.2015.06.041. Epub 2015 Jun 20.

DOI:10.1016/j.ijcard.2015.06.041
PMID:26142192
Abstract
摘要

相似文献

1
A novel quantitative assessment of whole blood thrombogenicity in patients treated with a non-vitamin K oral anticoagulant.对接受非维生素K口服抗凝剂治疗的患者全血血栓形成性的一种新型定量评估。
Int J Cardiol. 2015 Oct 15;197:98-100. doi: 10.1016/j.ijcard.2015.06.041. Epub 2015 Jun 20.
2
Nonvitamin K antagonist oral anticoagulants (NOACs): the tide continues to come in.非维生素K拮抗剂口服抗凝药（NOACs）：潮流仍在继续。
Vasc Health Risk Manag. 2015 Aug 20;11:489-92. doi: 10.2147/VHRM.S89736. eCollection 2015.
3
Vitamin K to reverse the anticoagulant effect of vitamin K antagonists: can you teach an old dog new tricks?维生素K逆转维生素K拮抗剂的抗凝作用：老狗能学新把戏吗？
J Thromb Haemost. 2010 Mar;8(3):496-8. doi: 10.1111/j.1538-7836.2009.03730.x. Epub 2009 Dec 21.
4
Orally active direct thrombin inhibitors.口服活性直接凝血酶抑制剂。
Semin Vasc Med. 2003 May;3(2):131-8. doi: 10.1055/s-2003-40671.
5
Assessing nonvitamin K antagonist oral anticoagulants (NOACs) in the laboratory.在实验室中评估非维生素K拮抗剂口服抗凝药（NOACs）。
Int J Lab Hematol. 2015 May;37 Suppl 1:46-51. doi: 10.1111/ijlh.12350.
6
The pharmacodynamics of the oral anticoagulant drugs.口服抗凝药物的药效学
Prog Hemost Thromb. 1974;2(0):175-213.
7
Mechanism of action and monitoring of anticoagulants.抗凝剂的作用机制与监测
Semin Thromb Hemost. 1986 Jan;12(1):1-11. doi: 10.1055/s-2007-1003530.
8
[Influence of the protein induced by vitamin K absence on thrombotest and hepaplastintest in the patients treated with oral anticoagulant].[维生素K缺乏诱导蛋白对口服抗凝剂治疗患者凝血酶原时间测定和肝促凝血酶原激酶试验的影响]
Rinsho Byori. 1983 Jan;31(1):105-9.
9
Letter to the editor.致编辑的信。
J Orthop Trauma. 2009 Aug;23(7):550; author reply 550. doi: 10.1097/BOT.0b013e3181b0fae9.
10
The new or non-vitamin K antagonist oral anticoagulants: what have we learned since their debut.新型或非维生素K拮抗剂口服抗凝药：自首次亮相以来我们学到了什么。
Semin Thromb Hemost. 2015 Mar;41(2):188-94. doi: 10.1055/s-0035-1544159. Epub 2015 Feb 15.

引用本文的文献

1
The Utility of Total Thrombus-Formation Analysis System (T-TAS) in the Thrombosis and Hemostasis Field: A Scoping Review.全血栓形成分析系统（T-TAS）在血栓形成与止血领域的应用：一项范围综述
Int J Lab Hematol. 2025 Apr;47(2):201-211. doi: 10.1111/ijlh.14403. Epub 2024 Dec 10.
2
Efficacy of platelet-inspired hemostatic nanoparticles on bleeding in von Willebrand disease murine models.血小板启发的止血纳米颗粒对 von Willebrand 病小鼠模型出血的疗效。
Blood. 2023 Jun 8;141(23):2891-2900. doi: 10.1182/blood.2022018956.
3
Japanese high bleeding risk criteria status predicts low thrombogenicity and bleeding events in patients undergoing percutaneous coronary intervention.
日本高出血风险标准状况可预测行经皮冠状动脉介入治疗患者的低血栓形成性和出血事件。
Cardiovasc Interv Ther. 2023 Jul;38(3):299-308. doi: 10.1007/s12928-023-00920-3. Epub 2023 Mar 6.
4
Comprehensive coagulation and fibrinolytic potential in the acute phase of pediatric patients with idiopathic nephrotic syndrome evaluated by whole blood-based rotational thromboelastometry.采用全血旋转血栓弹力描记法评估小儿特发性肾病综合征急性期的综合凝血和纤维蛋白溶解潜能。
Pediatr Nephrol. 2022 Jul;37(7):1605-1614. doi: 10.1007/s00467-021-05366-4. Epub 2022 Jan 8.
5
The Use of Total Thrombus Formation Analysis System as a Tool to Assess Platelet Function in Bleeding and Thrombosis Risk-A Systematic Review.全血栓形成分析系统在出血和血栓形成风险评估中的应用：系统评价。
Int J Mol Sci. 2021 Aug 10;22(16):8605. doi: 10.3390/ijms22168605.
6
Total Thrombus-Formation Analysis System can Predict 1-Year Bleeding Events in Patients with Coronary Artery Disease.全血栓形成分析系统可预测冠心病患者 1 年内出血事件。
J Atheroscler Thromb. 2020 Mar 1;27(3):215-225. doi: 10.5551/jat.49700. Epub 2019 Aug 8.
7
Sulfenamide and Sulfonamide Derivatives of Metformin - A New Option to Improve Endothelial Function and Plasma Haemostasis.二甲双胍的磺酰胺和磺酰胺衍生物——改善血管内皮功能和血浆止血的新选择。
Sci Rep. 2019 Apr 25;9(1):6573. doi: 10.1038/s41598-019-43083-z.
8
Reduction in thrombogenic activity and thrombocytopenia after transcatheter aortic valve implantation - The ATTRACTIVE-TTAS study.经导管主动脉瓣植入术后血栓形成活性降低与血小板减少症——ATTRACTIVE-TTAS研究
Int J Cardiol Heart Vasc. 2019 Mar 28;23:100346. doi: 10.1016/j.ijcha.2019.100346. eCollection 2019 Jun.
9
Direct Oral Anticoagulants Form Thrombus Different From Warfarin in a Microchip Flow Chamber System.直接口服抗凝剂在微流控芯片系统中形成的血栓与华法林不同。
Sci Rep. 2017 Aug 7;7(1):7399. doi: 10.1038/s41598-017-07939-6.
10
Total Thrombus-formation Analysis System Predicts Periprocedural Bleeding Events in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.全血栓形成分析系统预测经皮冠状动脉介入治疗的冠心病患者围手术期出血事件。
J Am Heart Assoc. 2017 Apr 24;6(4):e005263. doi: 10.1161/JAHA.116.005263.